What do you want to know about GLP‑1 medications?
Honest, sourced answers about Ozempic, Wegovy, Mounjaro, Zepbound and the pills that came after them. Written for people, not prescribers.
Start with your medication
Questions people ask most
See the full FAQCost & insuranceHow Much Does Semaglutide Cost Without Insurance in 2026?Without insurance, brand-name semaglutide now runs about $149 to $499 a month depending on which product and dose you take, far below the $1,027 to $1,349 list prices.Side effects & safetyHow to Manage Nausea on Semaglutide: What the Research and Labels SayNausea hits nearly half the people who start semaglutide at the weight-management dose, and the label itself explains why the dose schedule exists and what to do when a step up does not go well.Getting startedDo I Qualify for Wegovy, Zepbound or Another GLP-1?A plain-English walk through who each FDA-approved GLP-1 is actually labeled for, where the BMI 30 and BMI 27 rules come from, what counts as a weight-related condition, and why your insurance plan may use stricter rules than the FDA label.Stopping & switchingWhat Happens When You Stop Taking a GLP-1: The EvidenceRandomized trials, real-world databases and meta-analyses now give a fairly clear picture of what happens to weight, blood sugar, blood pressure and body composition after a GLP-1 stops - and where the numbers disagree.Compounded & telehealthIs Compounded Semaglutide Legal in 2026?Compounded semaglutide was never banned outright, but the two legal pathways that made it a mass-market product both closed, leaving only a narrow patient-specific exception that FDA has defined very tightly.Side effects & safetyCan You Drink Alcohol on Semaglutide?There is no alcohol warning on the semaglutide label, but there are three real reasons drinking feels different on this drug, and two randomized trials now show it changes how much people drink.
This week in GLP‑1 news
Full timeline, back to 2017- Safety
Rule 702 general causation hearing opens in MDL 3094
- Prices
Status check: the two Medicare prices for semaglutide in 2027 still have not been reconciled
- Safety
Still no NAION warning on any US tirzepatide label
- Safety
Australian regulator finds eight times the approved semaglutide dose in a product sold as retatrutide
- Safety
Court weighs expert evidence in the GLP-1 stomach injury MDL
- Research
EASD 2026 in Milan sets up the next round of competitor data
Browse all 218 guides
AlternativesResults & daily lifeCompounded & telehealthMedicationsPipelineSide effects & safetyHow-to guidesCultureCost & insuranceStopping & switchingFDA & regulationGetting startedCompaniesFoundayoLiraglutideSpecific groupsFAQInsurance navigationMarket & policyHow they workClinical trialsBeyond weight lossOzempicWegovyMounjaroZepboundSemaglutideTirzepatide